Mr. Joseph Jimenez is Independent Director of Colgate Palmolive Co. Mr. Jimenez was Chief Executive Officer of Novartis AG since February 2010. He joined Novartis AG in April 2007 as Head of the Consumer Health Division and became Head of the Pharmaceuticals Division in October 2007. Prior to joining Novartis AG, Mr. Jimenez served as an advisor for The Blackstone Group, a private equity firm, from 2006 to 2007. In 1998, Mr. Jimenez joined H.J. Heinz Company as President and Chief Executive Officer of Heinz?s North America business and, in 2002, became President and Chief Executive Officer of Heinz?s European business, a position he held until 2006. He began his career in brand management at The Clorox Company and later served as the president of two operating divisions at ConAgra Grocery Products .
Age: 52 Director Since 2010
The company has Return on Asset (ROA) of 19.11 % which means that for every $100 of asset it generated profit of $19.11. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 106.71 % which means that it produced $106.71 on every 100 dollars invested by current stockholders.
The company reports 5.23 B of total liabilities with total debt to equity ratio (D/E) of 2.19 which may imply that the company relies heavily on debt financing. ColgatePalmolive Co has Current Ratio of 1.2 indicating that it is in a questionable position to pay out its debt commitments in time.
Entity SummaryColgatePalmolive Company, together with its subsidiaries, manufactures and markets consumer solutions worldwide. ColgatePalmolive Co [CL] is traded on New York Stock Exchange in USA. It is located in New York City, NY and employs 37,700 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| CL NYSE
Currency: USD - US Dollar
Traded on New York Stock Exchange
ColgatePalmolive Co has less than 5.0 (%) percent chance of experiencing financial distress in the next 2 years of operations.
ColgatePalmo price boundaries
Promote ColgatePalmo and Joseph Jimenez